CLINICAL TRIALS PROFILE FOR BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
✉ Email this page to a colleague
All Clinical Trials for Budesonide; Formoterol Fumarate Dihydrate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00569712 ↗ | Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol | Completed | Astra Zeneca Canada | Phase 1 | 2007-01-01 | RATIONALE: Studying the genes expressed in samples of blood and lung fluid in the laboratory from patients receiving budesonide and formoterol may help doctors learn more about the effect of budesonide and formoterol on gene expression and biomarkers. PURPOSE: This clinical trial is studying genes in blood and lung fluid samples from patients with chronic obstructive pulmonary disease, with or without a previous diagnosis of lung cancer, or with asthma treated with budesonide and formoterol. |
| NCT00569712 ↗ | Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol | Completed | AstraZeneca | Phase 1 | 2007-01-01 | RATIONALE: Studying the genes expressed in samples of blood and lung fluid in the laboratory from patients receiving budesonide and formoterol may help doctors learn more about the effect of budesonide and formoterol on gene expression and biomarkers. PURPOSE: This clinical trial is studying genes in blood and lung fluid samples from patients with chronic obstructive pulmonary disease, with or without a previous diagnosis of lung cancer, or with asthma treated with budesonide and formoterol. |
| NCT00569712 ↗ | Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol | Completed | British Columbia Cancer Agency | Phase 1 | 2007-01-01 | RATIONALE: Studying the genes expressed in samples of blood and lung fluid in the laboratory from patients receiving budesonide and formoterol may help doctors learn more about the effect of budesonide and formoterol on gene expression and biomarkers. PURPOSE: This clinical trial is studying genes in blood and lung fluid samples from patients with chronic obstructive pulmonary disease, with or without a previous diagnosis of lung cancer, or with asthma treated with budesonide and formoterol. |
| NCT00964535 ↗ | Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics | Completed | Orion Corporation, Orion Pharma | Phase 1/Phase 2 | 2009-09-01 | The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbohaler in terms of the drug absorbed into the bloodstream. |
| NCT01386996 ↗ | Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler | Completed | Orion Corporation, Orion Pharma | Phase 1 | 2011-07-01 | The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream. |
| NCT01593826 ↗ | Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler | Completed | Orion Corporation, Orion Pharma | Phase 1 | 2012-05-01 | The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Budesonide; Formoterol Fumarate Dihydrate
Condition Name
Clinical Trial Locations for Budesonide; Formoterol Fumarate Dihydrate
Trials by Country
Clinical Trial Progress for Budesonide; Formoterol Fumarate Dihydrate
Clinical Trial Phase
Clinical Trial Sponsors for Budesonide; Formoterol Fumarate Dihydrate
Sponsor Name
